biblio

Found 3 results
Filters: Author is Weinmueller, Michael  [Clear All Filters]
2020
C. L. Meena, Singh, D., Weinmueller, M., Reichart, F., Dangi, A., Marelli, U. Kiran, Zahler, S., and Sanjayan, G. J., “Novel cilengitide-based cyclic RGD peptides as alpha nu beta(3) integrin inhibitors”, Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 8, p. 127039, 2020.
2019
F. Reichart, Maltsev, O. V., Kapp, T. G., Raeder, A. F. B., Weinmueller, M., Marelli, U. Kiran, Notni, J., Wurzer, A., Beck, R., Wester, H. Juergen, Steiger, K., Di Maro, S., Di Leva, F. Saverio, Marinelli, L., Nieberler, M., Reuning, U., Schwaiger, M., and Kessler, H., “Selective targeting of integrin alpha v beta 8 by a highly active cyclic peptide”, Journal of Medicinal Chemistry, vol. 62, no. 4, pp. 2024-2037, 2019.
2017
M. Weinmueller, Rechenmacher, F., Marelli, U. Kiran, Reichart, F., Kapp, T. G., Raeder, A. F. B., Di Leva, F. Saverio, Marinelli, L., Novellino, E., Munoz-Felix, J. M., Hodivala-Dilke, K., Schumacher, A., Fanous, J., Gilon, C., Hoffman, A., and Kessler, H., “Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3”, Angewandte Chemie-International Edition, vol. 56, no. 51, pp. 16405-16409, 2017.